［1］Chiang K，Zielinska AE，Shaaban AM，et al.PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression［J］.Cell Reports，2017，21(12)：3498-3513.
[2]SUN BE，FENG J，HUANG JF，et al.The research of expression and correlation between FOXP1 and FOXQ1 in NSCLC［J］.Journal of Nantong University(Medical Sciences)，2017，37(5)：419-424.［孙百尔，冯健，黄剑飞，等.NSCLC组织中FOXP1和FOXQ1的表达及相关性研究［J］.南通大学学报(医学版)，2017，37(5)：419-424.］
[3]ZHANG FM，LI SS，XU H，et al.Expression of FOXP1 in poorly differentiated prostate and bladder cancer［J］.Chinese Journal of Clinical and Experimental Pathology，2016，32(3)：326-328.［张凤梅，李胜水，许华，等.低分化前列腺癌和膀胱癌中FOXP1的表达［J］.临床与实验病理学杂志，2016，32(3)：326-328.］
[4]Gascoyne DM，Banham AH.The significance of FOXP1 in diffuse large B-cell lymphoma［J］.Leukemia & Lymphoma，2017，58(5)：1037-1051.
[5]Joseph RW，Kapur P，Serie DJ，et al.Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression［J］.Journal of Urology，2016，195(1)：180-187.
[6]DING CC，DONG Y.Expressions of PBRM1 and p53 in endometrial cancer and the correlations with pathological stage［J］.Maternal & Child Health Care of China，2014，29(31)：5046-5048.［丁聪聪，董悦.PBRM1和p53在子宫内膜癌中的表达及其与病理分期的相关性研究［J］.中国妇幼保健，2014，29(31)：5046-5048.］
[7]De SL，Palmans S，Govaere O，et al.Expression of FOXP1 and colorectal cancer prognosis［J］.Laboratory Medicine，2015，46(4)：299-311.
[8]da Costa WH，Rezende M，Carneiro FC，et al.PBRM1，a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma［J］.BJU Int，2013，113(5)：E157-E163.
[9]Hsiao KY，Lin YC，Gupta SK，et al.Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis［J］.Cancer Research，2017，77(9)：2339-2350.
[10]ZENG LF，TIAN G，YAO J.Diagnostic of serum tumor markers for colon cancer assessed with logistic regression analysis and PLS-DA model［J］.Chongqing Medicine，2017，46(8)：1038-1041.［曾龙飞，田刚，姚健.Logistic回归和PLS-DA模型评价肿瘤标志物对结肠癌的诊断价值［J］.重庆医学，2017，46(8)：1038-1041.］
[11]Suzuki-Kerr H，Baba Y，Tsuhako A，et al.Forkhead box protein p1 is dispensable for retina but essential for lens development［J］.Invest Ophthalmol Vis Sci，2017，58(4)：1916-1929.
[12]LIU J，SHANG X，SHA SM，et al.Expression and significance of forkhead box P1 in the tissues of gastric cancer［J］.Progress in Modern Biomedicine，2014，14(5)：814-818.［刘剑，尚鑫，沙素梅，等.转录因子FOXP1在胃癌组织中的表达及意义［J］.现代生物医学进展，2014，14(5)：814-818.］
[13]Choi EJ，Seo EJ，Kim DK，et al.FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells［J］.Oncotarget，2016，7(3)：3506-3519.
[14]ZHENG YM，GUO JS.Expression and implication of FOXP1 in human colorectal cancer［J］.Journal of Shanxi Medical University，2017，48(6)：602-604.［郑一鸣，郭建昇.FOXP1在结直肠癌中的表达及意义［J］.山西医科大学学报，2017，48(6)：602-604.］
[15]Maltais R，Trottier A，Roy J，et al.Pharmacokinetic profile of PBRM in rodents，a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments［J］.J Steroid Biochem Mol Biol，2017(178)：167-176.
[16]Joseph RW，Kapur P，Serie DJ，et al.Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression［J］.Journal of Urology，2016，195(1)：180-187.
[17]DANG YM，CHEN C，CHE TJ，et al.Analysis on the correlation between PBRM1 and P21 with endometrial cancer［J］.Progress in Modern Biomedicine，2014，14(1)：117-120.［党雅梅，陈城，车团结，等.PBRM1和P21蛋白在子宫内膜癌的表达及意义［J］.现代生物医学进展，2014，14(1)：117-120.］
[18]Huang L，Peng Y，Zhong G，et al.PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest［J］.Oncotarget，2015，6(18)：16366-16378.
[19]Mo D，Li C，Liang J，et al.Low PBRM1 identifies tumor progression and poor prognosis in breast cancer［J］.International Journal of Clinical & Experimental Pathology，2015，8(8)：9307.
[20]Li H，Yang P，Zhong G，et al.PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest［J］.Oncotarget，2015，6(18)：16366-16378.
[21]Zhao J，Li H，Zhou R，et al.Foxp1 regulates the proliferation of hair follicle stem cells in response to oxidative stress during hair cycling［J］.Plos One，2015，10(7)：e0131674.
[22]Macher-Goeppinger S，Keith M，Tagscherer KE，et al.PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas［J］.Journal of Pathology，2016，237(4)：460-471.